论文部分内容阅读
目的探讨分析盐酸氨溴索联合盐酸丙卡特罗用于小儿支气管肺炎的临床效果。方法 90例小儿支气管肺炎患儿,采用随机数字法将其分为对照组与观察组,每组45例。对照组给予常规抗感染联合盐酸氨溴索治疗,观察组在对照组治疗的基础上给予盐酸丙卡特罗治疗。观察两组患儿治疗效果以及治疗前后临床症状积分,记录两组患儿治疗不良反应。结果治疗后观察组治疗总有效率为97.78%,高于对照组的86.67%,差异具有统计学意义(P<0.05)。两组患儿治疗前症状积分比较差异无统计学意义(P>0.05),治疗后两组患儿症状积分均低于治疗前,且观察组低于对照组,差异具有统计学意义(P<0.05)。两组患儿不良反应发生率比较差异无统计学意义(P>0.05)。结论盐酸氨溴索联合盐酸丙卡特罗用于小儿支气管肺炎的治疗,能够有效改善患儿的临床症状,提高治疗有效率,无明显不良反应,值得临床广泛推广。
Objective To investigate the clinical effect of ambroxol hydrochloride combined with procaterol hydrochloride in children with bronchopneumonia. Methods Ninety children with bronchopneumonia were divided into control group and observation group by random number method, with 45 cases in each group. The control group was given routine anti-infective combined with ambroxol hydrochloride. The observation group was treated with procaterol hydrochloride on the basis of the control group. The therapeutic effects of both groups were observed and the scores of clinical symptoms before and after treatment were recorded. Adverse reactions were recorded in both groups. Results After treatment, the total effective rate of observation group was 97.78%, which was higher than that of control group (86.67%), the difference was statistically significant (P <0.05). There was no significant difference in symptom scores between the two groups before treatment (P> 0.05). After treatment, the symptom scores in both groups were lower than those before treatment, and the observation group was lower than the control group (P < 0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P> 0.05). Conclusion Ambroxol hydrochloride combined with procaterol hydrochloride for the treatment of pediatric bronchial pneumonia can effectively improve the clinical symptoms of children and improve the treatment efficiency, no obvious adverse reactions, it is worth widely clinical promotion.